Aethlon Medical to Present at 12th International Conference on Dialysis

Jan 19, 2010, 11:13 ET from Aethlon Medical, Inc.

SAN DIEGO, Jan. 19 /PRNewswire-FirstCall/ -- Aethlon Medical, Inc. (OTC Bulletin Board: AEMD) announced today that its Chief Science Officer, Dr. Richard H. Tullis, will give a clinical presentation of the Aethlon Hemopurifier® at the 12th International Conference on Dialysis on January 22nd.  The presentation will review treatment outcomes of dialysis patients infected with Hepatitis-C (HCV), and will discuss the additional use of the Hemopurifier® in HIV and Cancer care.  The conference will be held at the Marriott New Orleans in New Orleans, Louisiana.  Additional information, including the speaker agenda, can be accessed online at:


About Aethlon Medical

Aethlon Medical creates diagnostic and therapeutic device solutions for infectious disease and cancer. Our Hemopurifier® represents the first-in-class medical device to selectively adsorb viruses and immunosuppressive toxins from the bloodstream. The Hemopurifier® seeks to improve Hepatitis-C treatment outcomes and serves as a broad-spectrum treatment countermeasure against bioterror and pandemic threats. Additional information regarding Aethlon Medical can be accessed online at


RedChip Companies, Inc.

Jon Cunningham

1-800-733-2447, Ext. 107

Jim Joyce

Chairman, CEO

858.459.7800 x301

Jim Frakes

Senior VP Finance

858.459.7800 x300

SOURCE Aethlon Medical, Inc.